Mylan-Atovaquone/Proguanil 100 mg

Mylan-Atovaquone/Proguanil 100 mg tablets are a combination medication used for malaria prevention and treatment. This oral medication is manufactured by Mylan Pharmaceuticals ULC in Canada.

Mylan-Atovaquone/Proguanil 100 mg tablets are primarily used for the prevention and treatment of malaria, a mosquito-borne disease caused by parasites. This medication is often prescribed for travelers to areas where malaria is common. The combination of atovaquone and proguanil works together to interfere with the growth of parasites in the red blood cells.

Common effects of Mylan-Atovaquone/Proguanil 100 mg tablets may include nausea, vomiting, diarrhea, and stomach pain. Some users may also experience headache, dizziness, or fever. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare professional.

Mylan-Atovaquone/Proguanil 100 mg tablets should be used with caution in individuals with severe kidney or liver problems. It is important to follow the prescribed dosage and complete the full course of treatment, even if symptoms improve. This medication should be stored at room temperature, away from moisture and heat.

Mylan-Atovaquone/Proguanil 100 mg tablets may interact with certain medications, including antacids, metoclopramide, and drugs that affect liver enzymes. Alcohol consumption should be avoided while taking this medication, as it may increase the risk of side effects. Always inform your healthcare provider about all medications you are taking.